Main Article Content

Abstract

Aim

In liver diseases VDAC has play as important role because it triggering the opening of the mitochondrial porin ion channel that leads to mitochondrial damage and induce apoptic or necrotic hepatic cell death. The present study, the relationship between expression of mitochondrial VDAC may underlie the protective effect of Rheum emodi against carbon tetrachloride (CCl4) induced liver damage in Wister rats.


Methods

The protective potential of the total Anthraquinone glycoside fraction of Rheum emodi (TAGF Rheum emodi) was determined by evaluating Aminotransferase activity, mitochondrial membrane potential, calcium-induced liver MPT (Mitochondrial permeability transition) and VDAC expression.


Results

Pretreatment with a total Anthraquinone glycoside fraction of Rheum emodi showed significant preservation of mitochondrial membrane potential as compared to CCl4 control demonstrating the mitochondrial protection. In addition, pretreatment with TAGF Rheum emodi at various concentrations exerted a dose-dependent effect against sensitivity to mitochondrial swelling induced by calcium. In addition, TAGF (400 mg/kg) significantly increased the transcription and translation of VDAC.


Conclusion

The result obtained from the study suggests that TAGF of Rheum emodi significantly prevents the damage to liver mitochondria induced by CCl4through regulating the expression of VDAC.

Keywords

Rheum emodi Total Anthraquinone glycoside content mitochondria Voltage dependent anion channels

Article Details

How to Cite
Meesala Srinivasarao, Mangamoori Lakshminarasu, Tasneem Mohammed, & Mohammed Ibrahim. (2021). Hepatoprotective potential of Rheum emodi against ccl4-induced liver damage through regulation of voltage dependent anion channel expression . International Journal of Research in Pharmacology & Pharmacotherapeutics, 5(2), 123-131. https://doi.org/10.61096/ijrpp.v5.iss2.2016.123-131

References

  1. [1]. Itokazu Y, Segawa Y, Omata T. Effects of ZNC-2381, a new oral compound, on several hepatic injury models and on hepatocellular apoptosis in mice and rats. J Pharma Pharmacol. 2000; 52:531–8.
  2. [2]. Jaeschke H, Gujral JS, Bajt ML. Apoptosis and necrosis in liver disease. Liver Int. 2004; 24:85–90
  3. [3]. Newmeyer DD, Ferguson-Miller S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell. 2003; 112:481–90.
  4. [4]. Orrenius S. Mitochondrial regulation of apoptotic cell death. Toxicol Lett. 2004; 149:19–23.
  5. [5]. Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology.2006; 43: S31–S44.
  6. [6]. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J. 1999; 341:233–49.
  7. [7]. Kim JS, He L, Qian T, Lemasters JJ. Role of the mitochondrial permeability transition in apoptotic and necrotic death after ischemia/reperfusion injury to hepatocytes. Curr Mol Med. 2003; 3:527–35.
  8. [8]. Godbole A, Varghese J, Sarin A, Mathew MK. VDAC is a conserved element of death pathways in plant and animal systems. Biochim Biophys Acta. 2003; 1642:87–96.
  9. [9]. Nautiyal BP et al., Germinability, Productivity, productivity and economic viability of Rheum emodi wall. Ex Meissn. Cultivated, at lower altitude. Curr Sci 2003; 84:143-8.
  10. [10]. Lu M, Chen QH. Biochemical study of Chinese rhubarb. Inhibitory effects of anthraquinone on P388 leukemia in mice. J China Pharmacol Univ 1989; 20:155–7.
  11. [11]. Oshio H, Kawamura N. Determination of the laxative compounds in rhubarb by high performance liquid chromatography. Shoyakugaku Zasshi 1985; 39:131–8.
  12. [12]. Zhou XM, Chen QH. Biochemical study of Chinese rhubarb. Inhibitory effect of anthraquinone derivatives on sodium-potassium - ATPase of rabbit renal medulla and their diuretic action. Acta Pharm Sinic 1988; 23:17–20.
  13. [13]. Meesala Srinivasarao et al., Hepatoprotective Potential of Total Anthraquinone Fraction of Rheum emodi: In vitro and In vivo Studies: Journal of Medical and Pharmaceutical Innovation; 2 (11) 2015; 15-22.
  14. [14]. 14. Aprille, J.R.; Hom, J.A.; Rulfs, J. Liver and skeletal muscle mitochondrial function following burn injury. J. Trauma. 1977, 17, 279-287.
  15. [15]. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
  16. [16]. Elimadi, A.; Sapena, R.; Settaf, A. et al.. Attenuation of liver normothermic ischemia reperfusion injury by preservation of mitochondrial functions with S-15176, a potent trimetazidine derivative. Biochem. Pharmacol. 2001, 62(4), 509-516.
  17. [17]. Lee CS, Han JH et al., Differential effect of catecholamines and MPP on membrane permeability in brain mitochondria and cell viability in PC12 cells. Neurochem Int. 2002; 40:361–9.
  18. [18]. Hewawasam RP et al., Hepatoprotective effect of Epaltes divaricata extract on Carbon tetrachloride-induced hepatotoxicity in mice. Indian J Med Res. 2004; 120:30–4.
  19. [19]. Chaung SS, Lin CC, Lin J. The hepatoprotective effects of Limonium sinense against carbon tetrachloride and beta-D-galactosamine intoxication in rats. Phytother Res. 2003; 17:784–91.
  20. [20]. Gao J, Tang XH, Wang YP. Effective protection of Terminalia catappa L. leaves from damage-induced by Carbon tetrachloride in liver mitochondria. J Nutr Biochem. 2006; 17:177–82.
  21. [21]. Tang XH, Gao J, Fang F. Hepatoprotection of oleanolic acid is related to its inhibition on mitochondrial permeability transition. Am J Chin Med. 2005; 33:627–37.
  22. [22]. Morin D, Papadopoulos V, Tillement JP. Prevention of cell damage in ischemia: novel molecular targets in mitochondria. Expert Opin Ther Targets. 2002; 6:315–34.
  23. [23]. Elimadi A, Julliena V, Tillementa JP, Morina D. S-15176 inhibits mitochondrial permeability transition via a mechanism independent of its antioxidant properties. Eur J Biochem. 2003; 468:93–101.
  24. [24]. Premkumar A, Simantov R. Mitochondrial voltage-dependent anion channel is involved in dopamine-induced apoptosis. J Neurochem. 2002; 82:345–52.
  25. [25]. Massa R, Marliera LN, Martorana A. Intracellular localization and isoform expression of the voltage-dependent anion channel (VDAC) in normal and dystrophic skeletal muscle. J Muscle Res Cell Motil. 2000; 21:433–42.
  26. [26]. Shinohara Y, Ishida T, Hino M. Characterization of porin isoforms expressed in tumor cells. Eur J Biochem. 2000; 267:6067–73.